<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT201701025486N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2017-06-19</date_registration>
      <primary_sponsor>Vice chancellor for research, Iran University of Medical Sciences</primary_sponsor>
      <public_title>The Effect of High Power Laser Therapy on Knee Osteoarthritis .</public_title>
      <acronym>High Power Laser Therapy &amp; Knee Osteoarthritis</acronym>
      <scientific_title>The Effect of High Power Laser Therapy on Pain and Physical Performance of Patient with Knee Osteoarthritis in comparison with conventional physical therapy.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2016-09-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>62</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/5891</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: Randomization:&#13;
Random allocation of the subjects was done by using a random number table and block random sampling; A: HPLT &amp; B: CT (a block size of 4).&#13;
Block 1: AABB&#13;
Block 2: ABAB&#13;
Block 3: BBAA&#13;
Block 4: BABA&#13;
Block 5: ABBA&#13;
Block 6: BAAB&#13;
&#13;
 In this study the patient, the therapist, as well as the assessor will be blinded to the study groups.The exact type of physical modalities will not be inserted in the consent form so the patient will be blind to treatment.&#13;
&#13;
In this study, the patients in HPLT group will be treated on even days and the other group patients will receive their treatment on odd days, to be unaware of treatment programs.&#13;
The exact type of physical modalities will not be written in the consent form so the patients of each group will be blind to treatment. It should be noted that the exercise therapy protocol will be individually trained to the patient in the first day and an exercise therapy pamphlet with necessary pictures and explanations will be given to the patient to do exercises at home.&#13;
In addition to the therapists who are responsible for doing therapeutic interventions are different in even and odd days, thus they will be blind to the intervention of the groups. Also, the assessor, a sports medicine assistant, who will evaluate the outcomes pre and post intervention in sports medicine clinic , will be blind to the patients in groups.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Primary knee osteoarthritis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention 1 (for HPLT group): The patients will be treated by high-power laser through PYSIOMED system (Belgium ) while the patient lying supine with the knee at 30 ° flexion three times a week for 10 sessions. The applicator (size:6 cm) will be placed vertically in contact with the joint and the knee in longitudinal and perpendicular direction will be scanned and irradiated with HPLT for 8 minutes with a power of 5 watts, duty cycle of 70%, frequency of 30 Hz and energy density 60 joules per square centimeter. Intervention 2: Intervention 2( for the control group): The patients will be treated by Combined BTL-4825 S Topline including High-frequency TENS( Duration: 50 microseconds, pulse rate :100 Hz with a maximum intensity tolerable for the patient , two electrodes on either side of the knee ,the treatment time : 20 minutes ) and Ultrasound (frequency: 1 MHz, mode: Continuous, probe size: 5 cm, treatment time: 8 minutes in the medial and lateral parts of knee in the supine position and with acoustic gel.) three times a week for 10 sessions. Intervention 3: Intervention 3- Common protocol for both groups: &#13;
Exercise therapy: Also, both groups receive the same, standardized exercise therapy for knee osteoarthritis as follows: 1. Warm-up exercises: slow walking for 5 minutes, hamstring stretch and calf stretch. 2. Major exercises for knee osteoarthritis: SLR (Straight Leg Raise), quadriceps setting, pillow squeeze, heel raise, one leg balance, step ups, quadriceps strengthening exercise. &#13;
Medication: In order to unify the participants’ medications, all patients will be asked to stop taking their medications one week before the beginning the study and Acetaminophen will prescribe for them at a dose of two grams per day.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Azar Moezy</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sports Medicine Clinic, Hazrat Rasool Akram Hospital- Sattarkhan Ave, Niayesh St,</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>14455613131</zip>
        <telephone>+98 21 6435 2446</telephone>
        <email>azarmoezy@yahoo.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Azar Moezy</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sports Medicine Department, Hazrat Rasool Akram Hospital- Sattarkhan Ave, Niayesh St,</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>14455613131</zip>
        <telephone>+98 21 6435 2446</telephone>
        <email>azarmoezy@yahoo.com</email>
        <affiliation>Iran University of Medical Sciences.</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria: primary OA of the knee joint grade 2, 3 according Kellgren and Lawrence  scale; age between 50-75; suffering from knee pain for at least six months and with intensity 3 on the VAS scale in activities such as going up and down stairs, sitting and squat; no history of knee intra-articular injection in the past six months; no history of acute traumatic injuries; no history of previous surgery or injury in the knee joints and lower extremities; having a referral from a doctor; BMI equal to or less than 30; patient's consent to participate in the research; lack of neuromuscular disease; normal mental state; absence of bone implants; no history of new fractures; lack of cancerous tumors; no history of chronic disease such as epilepsy, migraine, acute hernia and generally any disease or condition that is known to affect the investigation; participate in sports programs and physical therapy in the recent three months.&#13;
Exclusion criteria: unwillingness to participate in the study; uncompleted evaluation programs; uncompleted treatment programs; any damage in the knee joint during the study; using any other treatment except for the treatment prescribed in the research project.</inclusion_criteria>
      <agemin>50 years</agemin>
      <agemax>75 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M17.0 ,M17</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Gonarthrosis [arthrosis of knee]</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention 1 (for HPLT group): The patients will be treated by high-power laser through PYSIOMED system (Belgium ) while the patient lying supine with the knee at 30 ° flexion three times a week for 10 sessions. The applicator (size:6 cm) will be placed vertically in contact with the joint and the knee in longitudinal and perpendicular direction will be scanned and irradiated with HPLT for 8 minutes with a power of 5 watts, duty cycle of 70%, frequency of 30 Hz and energy density 60 joules per square centimeter.</i_keyword>
      <i_keyword>Intervention 2( for the control group): The patients will be treated by Combined BTL-4825 S Topline including High-frequency TENS( Duration: 50 microseconds, pulse rate :100 Hz with a maximum intensity tolerable for the patient , two electrodes on either side of the knee ,the treatment time : 20 minutes ) and Ultrasound (frequency: 1 MHz, mode: Continuous, probe size: 5 cm, treatment time: 8 minutes in the medial and lateral parts of knee in the supine position and with acoustic gel.) three times a week for 10 sessions.</i_keyword>
      <i_keyword>Intervention 3- Common protocol for both groups: &#13;
Exercise therapy: Also, both groups receive the same, standardized exercise therapy for knee osteoarthritis as follows: 1. Warm-up exercises: slow walking for 5 minutes, hamstring stretch and calf stretch. 2. Major exercises for knee osteoarthritis: SLR (Straight Leg Raise), quadriceps setting, pillow squeeze, heel raise, one leg balance, step ups, quadriceps strengthening exercise. &#13;
Medication: In order to unify the participants’ medications, all patients will be asked to stop taking their medications one week before the beginning the study and Acetaminophen will prescribe for them at a dose of two grams per day.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: pre / post intervention and  three months after the intervention. Method of measurement: VAS pain scale.</prim_outcome>
      <prim_outcome>Active knee range of motion. Timepoint: Pre / post intervention and  three months after the intervention. Method of measurement: Goniometer.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Joint stiffness and functional state. Timepoint: Pre/Post and three months after Intervention. Method of measurement: Western Ontario and McMaster Universities Osteoarthritis Index.</sec_outcome>
      <sec_outcome>Functional Activity. Timepoint: Pre/Post and three months after Intervention. Method of measurement: Timed Up &amp; Go Test / Six-Minute Walk Test.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice chancellor for research, Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-10-18</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Sports Medicine Department, Hazrat Rasool Akram Hospital- Sattarkhan Ave, Niayesh St. Tehran  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
